Navigation Links
Wisconsin applicants urged to pursue DOE funding for cellulosic biomass

ligible for consideration:

The mass of biomass feedstock throughput is at least 70 dry metric tons per day, or a minimum of 1.5 million gallons per year of biofuel must be produced.

Transportation biofuels must be the primary product and are limited to ethanol, biodiesel, biobutanol, or any fungible replacement for gasoline or diesel as a transportation fuel produced from terre......

Full article >>>
'"/>

Source:wistechnology.com By Greg Lynch 05/24/07


Page: 1 2

Related biology technology :

1. To be a player in the "Knowledge Economy," Wisconsin needs more tech workers
2. Federal bioenergy lab will give Wisconsin a chance to shine
3. Breaking down Wisconsins angel capital numbers
4. Innovation featured in NE Wisconsin Roundtable
5. Visions: Broderick says Wisconsin should be in top third in venture capital
6. Wisconsin building toward the major leagues of venture capital
7. Wisconsin Supreme Court to hear Menasha software case
8. Legislature should look to Wisconsins natural energy advantages
9. Stem cells get most attention, but they are only part of Wisconsins bio-portfolio
10. BIO 2007: Wisconsin makes its presence felt
11. Getting noticed in Genetown: Wisconsin biotech on display
Post Your Comments:
(Date:5/17/2012)... 2012   Pharmaceutical companies that are first ... an advantage in the competition for market share and ... the Health Research Institute (HRI) at PwC US.  Physicians, ... well a drug will work and affect total medical ... finds the information currently provided by the biopharmaceutical industry ...
(Date:5/16/2012)... paralyzed woman was able to reach for and sip from ... in nearly 15 years by using her thoughts to ... by the National Institutes of Health, is evaluating the safety ... interface system. This is a type of brain-computer interface ... the brain,s control. , A report published today in ...
(Date:5/16/2012)... 16, 2012 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited ... manufacturer and marketer of medical devices worldwide, announced ... renewing its agreement for its full line of ... agreement, Mindray provides monitoring that can meet the ... outpatient surgery centers for HealthTrust members. The new ...
(Date:5/15/2012)... 2012  OrbusNeich today announced that 12-month follow-up data ... outcomes involving the use of the company,s Combo Dual ... Liberte ® paclitaxel-eluting stent. The data were presented ... the Lukaskrankenhaus in Neuss, Germany, at EuroPCR 2012. ... clinically driven target lesion failure (TLF) rate was 8.9% ...
Breaking Biology Technology:New Competitive Arena Emerges for Pharmaceutical Companies in Healthcare's Changing Payment Landscape, Finds PwC Health Research Institute Study 2New Competitive Arena Emerges for Pharmaceutical Companies in Healthcare's Changing Payment Landscape, Finds PwC Health Research Institute Study 3New Competitive Arena Emerges for Pharmaceutical Companies in Healthcare's Changing Payment Landscape, Finds PwC Health Research Institute Study 4New Competitive Arena Emerges for Pharmaceutical Companies in Healthcare's Changing Payment Landscape, Finds PwC Health Research Institute Study 5New Competitive Arena Emerges for Pharmaceutical Companies in Healthcare's Changing Payment Landscape, Finds PwC Health Research Institute Study 6Paralyzed individuals use thought-controlled robotic arm to reach and grasp 2Paralyzed individuals use thought-controlled robotic arm to reach and grasp 3Paralyzed individuals use thought-controlled robotic arm to reach and grasp 4Paralyzed individuals use thought-controlled robotic arm to reach and grasp 5Mindray Renews Agreement with HealthTrust Purchasing Group, L.P. to Provide Patient Monitoring Equipment 2OrbusNeich's Combo Dual Therapy Stent™ Demonstrates Favorable Clinical and Safety Outcomes at 12-Month Follow-Up 2OrbusNeich's Combo Dual Therapy Stent™ Demonstrates Favorable Clinical and Safety Outcomes at 12-Month Follow-Up 3OrbusNeich's Combo Dual Therapy Stent™ Demonstrates Favorable Clinical and Safety Outcomes at 12-Month Follow-Up 4
... RT-PCR , , ... reliable solutions for long-range,amplification from genomic DNA and cDNA. Low error rates are assured using ... QIAGEN LongRange PCR and 2Step RT-PCR Kits provide: ... up to 40 kb DNA or,12.5 kb cDNA , ...
... Human plasma and serum represents an important biological ... wide dynamic range in protein concentration , ... the very low concentration of biomarker proteins in the ... practical and effective strategy is to remove 99% , ...
... Promega Corporation, Madison, WI, USA , ... 139 , ... , Multiplexing homogeneous cell-based assays for analysis of different , ... and cell viability , Assay miniaturization up to 1536-well format , ...
Other Biology Technology:QIAGEN LongRange PCR and 2Step RT-PCR Kits 2Protein Depletion for Plasma and Serum Proteomic Analysis 2Protein Depletion for Plasma and Serum Proteomic Analysis 3Protein Depletion for Plasma and Serum Proteomic Analysis 4Protein Depletion for Plasma and Serum Proteomic Analysis 5Protein Depletion for Plasma and Serum Proteomic Analysis 6Protein Depletion for Plasma and Serum Proteomic Analysis 7Protein Depletion for Plasma and Serum Proteomic Analysis 8Protein Depletion for Plasma and Serum Proteomic Analysis 9Protein Depletion for Plasma and Serum Proteomic Analysis 10Protein Depletion for Plasma and Serum Proteomic Analysis 11Protein Depletion for Plasma and Serum Proteomic Analysis 12Protein Depletion for Plasma and Serum Proteomic Analysis 13Protein Depletion for Plasma and Serum Proteomic Analysis 14Protein Depletion for Plasma and Serum Proteomic Analysis 15Protein Depletion for Plasma and Serum Proteomic Analysis 16Protein Depletion for Plasma and Serum Proteomic Analysis 17Protein Depletion for Plasma and Serum Proteomic Analysis 18Protein Depletion for Plasma and Serum Proteomic Analysis 19Protein Depletion for Plasma and Serum Proteomic Analysis 20Protein Depletion for Plasma and Serum Proteomic Analysis 21Protein Depletion for Plasma and Serum Proteomic Analysis 22Protein Depletion for Plasma and Serum Proteomic Analysis 23Protein Depletion for Plasma and Serum Proteomic Analysis 24Protein Depletion for Plasma and Serum Proteomic Analysis 25Protein Depletion for Plasma and Serum Proteomic Analysis 26Protein Depletion for Plasma and Serum Proteomic Analysis 27Protein Depletion for Plasma and Serum Proteomic Analysis 28Protein Depletion for Plasma and Serum Proteomic Analysis 29Protein Depletion for Plasma and Serum Proteomic Analysis 30Protein Depletion for Plasma and Serum Proteomic Analysis 31Protein Depletion for Plasma and Serum Proteomic Analysis 32Promegas Multiplexed Luciferase Reporter and Cell Viability Assays performed on the PHERAstar 2Promegas Multiplexed Luciferase Reporter and Cell Viability Assays performed on the PHERAstar 3Promegas Multiplexed Luciferase Reporter and Cell Viability Assays performed on the PHERAstar 4
(Date:5/21/2012)... Centre of Finland have in collaboration with the ... companies, Biotie Therapies Corp. and Pharmatest Services Ltd, ... breast cancer bone metastases and showed that heparin-like ... cancer metastasis to bone. , These findings ... journal website on 20th April 2012. , ...
(Date:5/21/2012)... of Australian and US scientists has found there has ... Bottom Water found off the coast of Antarctica.,Comparing detailed ... Ocean marine science voyage to historical data dating back ... as a 60 per cent reduction in the volume ... drives global ocean currents. , In an intensive and ...
(Date:5/20/2012)... of researchers from UCSF and UC San Diego has ... amoebas in lab and animal studies, suggesting it could ... infections that cause human dysentery throughout the world. ... Orphan Drug Status for the drug, known as auranofin, ... applied for approval to start clinical trials to treat ...
Breaking Biology News(10 mins):Latest Southern Ocean research shows continuing deep ocean change 2Latest Southern Ocean research shows continuing deep ocean change 3Lab tests show arthritis drug effective against global parasite 2Lab tests show arthritis drug effective against global parasite 3Lab tests show arthritis drug effective against global parasite 4Study suggests possible new treatment for severe 2009 H1N1 infection 78515 1New romaine lettuce lines launched 17347 1New romaine lettuce lines launched 17347 2Study finds psychological environmental benefits of horticultural activities 17345 1Study finds psychological environmental benefits of horticultural activities 17345 2
... This release is available in French . ... the oldest drugs known to humans, and its abuse has ... the same time, we know rather little about its effects ... cocaine addiction. The latest article by Dr. Marco Leyton, of ...
... Charles Darwin described the sudden origin of flowering plants about ... scientists have yet to solve. , But a new ... the online edition of the Proceedings of the National ... mystery with information about what the first flowers looked like ...
... The carnivorous reptiles ( Varanus komodoensis ) are known to ... death from their wounds: the victims are reported to go ... Some researchers believe that prey are killed by pathogenic bacteria ... in the latest issue of Proceedings of the ...
Other Biology News:Cocaine: Perceived as a reward by the brain? 2University of Florida study provides insight into evolution of first flowers 2University of Florida study provides insight into evolution of first flowers 3Komodo even more deadly than thought: Research 2
... array sample elements. , , ,Includes: , , ... in PBS (10X): 50 ml , Streptavidin ... 8 packs , 10% Tween-20: 2 x 10 ... x 25 ml , SuperSignal West Pico Stable Peroxide: ...
... The Partec Cell Counter Analyser counts cells ... the CCA detects only cells, so that ... the results.,While passing through a 250 m ... fluorescence light signal which is used as ...
... Accurate Results Laser Capture Microdissection (LCM) ... and accuracy of molecular assays by starting ... multi-cellular structures isolated from whole tissue or ... in 1996 at the National Institutes of ...
Mouse monoclonal antibody raised against a partial recombinant DHX8. NCBI Entrez Gene ID = DHX8...
Biology Products: